| Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions AR Shiakolas, KJ Kramer, D Wrapp, SI Richardson, A Schäfer, S Wall, ... Cell Reports Medicine 2 (6), 2021 | 71 | 2021 |
| Distinct patterns of clonal evolution drive myelodysplastic syndrome progression to secondary acute myeloid leukemia T Guess, CR Potts, P Bhat, JA Cartailler, A Brooks, C Holt, A Yenamandra, ... Blood Cancer Discovery 3 (4), 316-329, 2022 | 37 | 2022 |
| Potent neutralization of SARS-CoV-2 variants of concern by an antibody with an uncommon genetic signature and structural mode of spike recognition KJ Kramer, NV Johnson, AR Shiakolas, N Suryadevara, S Periasamy, ... Cell Reports 37 (1), 2021 | 28 | 2021 |
| Distinct Patterns of Clonal Evolution Drive Myelodysplastic Syndrome Progression to Secondary Acute Myeloid Leukemia. Blood Cancer Discovery. 2022; 3 (4): 316–329. doi: 10.1158 … T Guess, CR Potts, P Bhat, JA Cartailler, A Brooks, C Holt, A Yenamandra, ... BCD-21-0128, 0 | 8 | |
| Cross-reactive coronavirus antibodies with diverse epitope specificities and extra-neutralization functions AR Shiakolas, KJ Kramer, D Wrapp, SI Richardson, A Schäfer, S Wall, ... bioRxiv, 2020.12. 20.414748, 2020 | 7 | 2020 |
| Discovery and Characterization of a Pan-betacoronavirus S2-binding antibody NV Johnson, SC Wall, KJ Kramer, CM Holt, S Periasamy, SI Richardson, ... Structure 32 (11), 1893-1909. e11, 2024 | 5 | 2024 |
| SARS-CoV-2 antibodies from children exhibit broad neutralization and belong to adult public clonotypes SC Wall, N Suryadevara, C Kim, AR Shiakolas, CM Holt, EB Irbe, ... Cell Reports Medicine 4 (11), 2023 | 5 | 2023 |
| Distinct patterns of clonal evolution drive myelodysplastic syndrome progression to secondary acute myeloid leukemia. Blood Cancer Discov. 3, 316–329 T Guess, CR Potts, P Bhat, JA Cartailler, A Brooks, C Holt, A Yenamandra, ... | 5 | 2022 |
| Adaptation of a transmitted/founder simian-human immunodeficiency virus for enhanced replication in rhesus macaques A Bauer, E Lindemuth, FE Marino, R Krause, J Joy, SS Docken, S Mallick, ... PLoS Pathogens 19 (7), e1011059, 2023 | 4 | 2023 |
| Specific molecular recognition as a strategy to delineate tumor margin using topically applied fluorescence embedded nanoparticles S Barton, B Li, M Siuta, J Vaibhav, J Song, CM Holt, T Tomono, M Ukawa, ... Precision nanomedicine 1 (3), 194, 2018 | 2 | 2018 |
| Potent HPIV3-neutralizing IGHV5-51 Antibodies Identified from Multiple Individuals Show L Chain and CDRH3 Promiscuity AA Abu-Shmais, RJ Miller, AK Janke, RM Wolters, CM Holt, N Raju, ... The Journal of Immunology 212 (9), 1450-1456, 2024 | 1 | 2024 |
| Variant library-coupled immunogenicity mapping of monoclonal antibody therapeutics J Goettel, J Jacobse, I Georgiev, L Walker, C Holt US Patent App. 18/428,118, 2024 | | 2024 |
| Generation of antigen-specific paired heavy-light chain antibody sequences using large language models PT Wasdin, NV Johnson, AK Janke, S Held, TM Marinov, G Jordaan, ... bioRxiv, 2024.12. 20.629482, 2024 | | 2024 |
| Mo1956 MAPPING IMMUNOGENIC EPITOPES OF ADALIMUMAB USING VALIMABSEQ J Jacobse, LM Walker, C Holt, J Li, JM Pilat, D Beaulieu, SN Horst, ... Gastroenterology 164 (6), S-944, 2023 | | 2023 |
